Want to see QTEX full AI Analyst Report?
Top Page
QTREX Quantum Ltd
(NASDAQ:QTEX)
Select Model
Select Model
Rating:41Neutral
Price Target:
$0.75
▼(-12.91% Downside)
Action:Reiterated
Date:10/02/26
QTEX scores low primarily due to very weak financial performance—minimal/unstable revenue, sustained large losses, and heavy persistent cash burn that pressures liquidity and equity. Technical indicators add further downside risk with the stock trading below key moving averages and negative MACD. Valuation is not supportive because losses drive a negative P/E and there is no indicated dividend yield.
Positive Factors
Emerging Quantum Revenue
The sharp first-half revenue increase indicates that the acquired AME platform is beginning to convert technical capability into commercial activity. If early orders and validation projects become recurring deployments, quantum connectivity could become a more meaningful and durable revenue engine.
Negative Factors
Persistent Unprofitability
Very low and inconsistent revenue combined with negative gross profit shows that the business has not yet established profitable operating leverage. Continued losses can constrain reinvestment, weaken financial resilience, and make the timing of sustainable earnings dependent on successful commercial conversion.
Read all positive and negative factors
Positive Factors
Negative Factors
Emerging Quantum Revenue
The sharp first-half revenue increase indicates that the acquired AME platform is beginning to convert technical capability into commercial activity. If early orders and validation projects become recurring deployments, quantum connectivity could become a more meaningful and durable revenue engine.
Read all positive factors
QTREX Quantum Ltd (QTEX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$45.75M
Dividend YieldN/A
Average Volume (3M)2.70M
Price to Earnings (P/E)―
Beta (1Y)3.67
Revenue Growth437.72%
EPS Growth24.01%
CountryUS
Employees34
SectorTechnology
Sector Strength88
IndustryComputer Hardware
Share Statistics
EPS (TTM)-0.24
Shares Outstanding67,075,040
10 Day Avg. Volume2,233,735
30 Day Avg. Volume2,704,341
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)11.48
Price to Sales (P/S)92.25
P/FCF Ratio-2.68
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit0.03
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.1
Revenue Forecast (FY)$48.00M
QTREX Quantum Ltd Business Overview & Revenue Model
Company Description
QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. T...
QTREX Quantum Ltd Financial Statement Overview
Summary
Income Statement
8
Very Negative
Balance Sheet
34
Negative
Cash Flow
10
Very Negative
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
QTREX Quantum Ltd Technical Analysis
Neutral
0.86
Price Trends
0.88
Negative
1.17
Negative
0.92
Negative
Market Momentum
-0.05
Positive
45.57
Neutral
44.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For QTEX, the sentiment is Neutral. The current price of 0.86 is above the 20-day moving average (MA) of 0.81, below the 50-day MA of 0.88, and below the 200-day MA of 0.92, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 45.57 is Neutral, neither overbought nor oversold. The STOCH value of 44.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for QTEX.
QTREX Quantum Ltd Risk Analysis
QTREX Quantum Ltd disclosed 70 risk factors in its most recent earnings report. QTREX Quantum Ltd reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
QTREX Quantum Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $4.21B | 21.70 | 15.41% | ― | 12.39% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
51 Neutral | $82.03M | -1.67 | -96.66% | ― | -3.43% | 19.16% | |
45 Neutral | $12.29M | -0.69 | -445.14% | ― | 8.64% | -61.01% | |
44 Neutral | $2.72M | -0.05 | -734.86% | ― | 60.75% | 71.34% | |
44 Neutral | $54.51M | -0.39 | -94.35% | ― | 31.52% | -89.07% | |
41 Neutral | $45.75M | -1.27 | -278.14% | ― | 437.72% | 24.01% |
* Technology Sector Average
QTEX
QTREX Quantum Ltd
0.78
-0.40
-33.56%
CTSO
Cytosorbents
4.19
-15.52
-78.76%
LIVN
LivaNova
74.70
23.47
45.81%
XAIR
Beyond Air
2.93
-47.07
-94.14%
NNOX
Nano-X Imaging
0.66
-3.13
-82.53%
LUNG
Pulmonx
1.91
0.22
13.02%
QTREX Quantum Ltd Corporate Events
QTREX Quantum Reports Breakthrough Cryogenic Interconnect Test, Moves to Finalize Major Quantum Agreement
Oct 1, 2026
On October 1, 2026, QTREX Quantum announced independent tests of its additively manufactured cryogenic interconnect by a leading quantum computing company, conducted at 20 millikelvin using the tester’s own cryogenic system and instruments. ...
QTREX Quantum Posts Record H1 2026 Revenue and Launches INSU300 for Superconducting Quantum Systems
Sep 24, 2026
QTREX Quantum reported record first-half 2026 revenue of $1.55 million, a 438% year-on-year increase, all generated in the AME and Quantum segment’s first 86 days after the April 6, 2026 acquisition of its AME platform. Despite a consolidate...
QTREX Quantum Secures Major Defense Partner for AME Deployment
Sep 2, 2026
On September 2, 2026, QTREX Quantum announced that one of Israel’s three largest defense companies, a major global aerospace and defense player, has begun deploying its AME technology under a joint development program targeting strategic sys...
QTREX Quantum Shareholders Approve New Articles but Reject Pay Policy at August Meeting
Aug 28, 2026
On August 28, 2026, QTREX Quantum Ltd held its Annual and Extraordinary General Meeting of Shareholders in Israel, where a quorum was present and investors voted on multiple corporate proposals. Shareholders approved Proposal Nos. 1, 2 and 4 throu...
QTREX Quantum Secures $10 Million Registered Direct Equity Financing
Aug 20, 2026
On August 20, 2026, QTREX Quantum Ltd. entered into a securities purchase agreement with institutional investors for a registered direct offering of 11,111,111 ordinary shares at $0.90 per share, for expected gross proceeds of about $10 million. T...
QTREX Quantum Unveils Graphene-Like 3D-Printed Insulation Breakthrough for Quantum Processor Protection
Aug 19, 2026
On August 19, 2026, QTREX Quantum announced a patent‑pending technology that uses localized laser processing to directly convert its 3D‑printed dielectric insulation into electrically conductive, graphene‑like carbon structures, ...
QTREX Quantum’s Interconnect Platform Clears Strategic RF Performance Bar
Aug 3, 2026
On July 31, 2026, QTREX Quantum Ltd. announced that its proprietary printed coaxial quantum interconnect platform exceeded RF performance thresholds set by strategic partners as part of a qualification process. The validation, which showed continu...
QTREX Quantum Launches Northeastern University Collaboration to Advance Cryogenic Quantum Interconnects
Jul 27, 2026
On July 27, 2026, QTREX Quantum Ltd. announced a research collaboration with Northeastern University to develop advanced micro-system structures for cryogenic quantum interconnects, giving QTREX a first option to negotiate commercial licenses to N...
QTREX Quantum Calls August 28 Meeting to Approve Board, Pay and Capital Changes
Jul 24, 2026
QTREX Quantum Ltd., an Israeli technology company listed in the U.S., has convened an Annual and Extraordinary General Meeting of shareholders for August 28, 2026 in Ra’anana. The firm, which reports as a foreign private issuer and uses SEC ...
Qtrex Quantum Expands Equity Incentive Share Pool in July 2026
Jul 21, 2026
On July 6, 2026, Qtrex Quantum Ltd.’s board approved an increase in the ordinary shares reserved for issuance under its Amended and Restated 2019 Equity Incentive Plan, expanding the pool by 3,834,244 shares from 11,875,977 to 15,710,221. Th...
QTREX Quantum Adds AME Veteran Dr. Shlomit Chappel-Ram to Board as Independent Director
Jul 17, 2026
QTREX Quantum Ltd., a Nasdaq-listed developer of advanced connectivity and AME-based electronics for quantum, defense and medical markets, is building high-density quantum connectivity solutions and mission-critical AME components while seeking to...
QTREX Quantum Secures Custom RF Components Order, Launches Production for Government Client
Jul 14, 2026
On July 14, 2026, QTREX Quantum announced it had secured a commercial purchase order from a leading international government‑owned company for customized Shielded RF Monolithic components following extensive testing and qualification. The co...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.